The laboratory of organic synthesis, analytical and medicinal chemistry

Specifically, our ongoing research area includes: 

1. Development of nitric oxide (NO) and hydrogen sulfide (H2S) hybrid donor compounds based on cannabinoid scaffold and exploring their dual activity in cardiovascular- and neurodegenerative-related diseases. 
2. Development of Schiff bases-cannabinoid hybrid compounds and evaluation of their biological activity on the melanogenesis process.
3. Development of Platinum-hybrid complexes, with a particular focus on their potential as anti-cancer drugs. (in collaboration with Prof. Jamal Mahajna)

Additionally, we are focusing on microencapsulation technology to encapsulate bioactive compounds. We investigate their stability and controlled release, aiming to extend the shelf life of a diverse range of food products.

Our group members:
Yuval Peretz, Lab manager
Eliav Peretz, Master student
Noor Amara, Master student
Gil Dinnar, Research Assistant